Cardiopulmonary exercise testing in the assessment of pulmonary hypertension

References

• Sanchez O, Marie E, Lerolle U et al. Pulmonary arterial hypertension in women. Rev. Mal. Respir.27(8), e79–e87 (2010).
   Google Scholar
• De MT. Pulmonary arterial hypertension and women. Cardiol. Rev.14(6), 312–318 (2006).
   PubMedGoogle Scholar
• Galie N, Hoeper MM, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J.34(6), 1219–1263 (2009).
   PubMed Web of Science ®Google Scholar
• Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N. Engl. J. Med.351(14), 1425–1436 (2004).
   PubMed Web of Science ®Google Scholar
• McGoon M, Gutterman D, Steen V et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension. Chest126(Suppl. 1), 14S–34S (2004).
   PubMed Web of Science ®Google Scholar
• Steen V, Chou M, Shanmugam V et al. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest134(1), 146–151 (2008).
   PubMed Web of Science ®Google Scholar
• Thomas AQ, Gaddipati R, Newman JH, Loyd JE. Genetics of primary pulmonary hypertension. Clin. Chest Med.22(3), 477–491, IX (2001).
   PubMed Web of Science ®Google Scholar
• Rich S, Dantzker DR, Ayres SM et al. Primary pulmonary hypertension. A national prospective study. Ann. Intern. Med.107(2), 216–223 (1987).
   PubMed Web of Science ®Google Scholar
• Arena R, Lavie CJ, Milani RV, Myers J, Guazzi M. Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J. Heart Lung Transplant.29(2), 159–173 (2010).
   PubMed Web of Science ®Google Scholar
• Damy T, Goode KM, Kallvikbacka-Bennett A et al. Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. Eur. Heart J.31(18), 2280–2290 (2010).
   PubMed Web of Science ®Google Scholar
• Adhyapak SM. Effect of right ventricular function and pulmonary pressures on heart failure prognosis. Prev. Cardiol.13(2), 72–77 (2010).
   PubMedGoogle Scholar
• Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management. Chest137(Suppl. 6), 39S–51S (2010).
   PubMed Web of Science ®Google Scholar
• Park MH, Scott RL, Uber PA, Ventura HO, Mehra MR. Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. Congest. Heart Fail.10(5), 221–225 (2004).
   PubMedGoogle Scholar
• Hinderliter AL, Willis PW, Barst RJ et al. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation95(6), 1479–1486 (1997).
   PubMed Web of Science ®Google Scholar
• Groepenhoff H, Vonk-Noordegraaf A, Boonstra A et al. Exercise testing to estimate survival in pulmonary hypertension. Med. Sci. Sports Exerc.40(10), 1725–1732 (2008).
   PubMed Web of Science ®Google Scholar
• Balady GJ, Arena R, Sietsema K et al. Clinician’s guide to cardiopulmonary exercise testing in adults. a scientific statement from the American Heart Association. Circulation122(2), 191–225 (2010).
   PubMed Web of Science ®Google Scholar
• Gibbons RJ, Balady GJ, Timothy BJ et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J. Am. Coll. Cardiol.40(8), 1531–1540 (2002).
   PubMed Web of Science ®Google Scholar
• Wasserman K, Hansen JE, Sue DY, Whipp BJ. Principles of Exercise Testing and Interpretation. Lea and Febiger, Philadelphia, PA, USA (2005).
   Google Scholar
• Hsia CC, Johnson RL Jr. Comprehensive Textbook of Pulmonary and Critical Care Medicine. Bone R (Ed.). Mosby-Yearbook, St Louis, MO, USA, 1–20 (1993).
   Google Scholar
• D’Alonzo GE, Gianotti LA, Pohil RL et al. Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension. Chest92(1), 57–62 (1987).
   PubMed Web of Science ®Google Scholar
• Yasunobu Y, Oudiz RJ, Sun XG, Hansen JE, Wasserman K. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest127(5), 1637–1646 (2005).
   PubMed Web of Science ®Google Scholar
• Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation105(1), 54–60 (2002).
   PubMed Web of Science ®Google Scholar
• Arena R, Myers J, Williams MA et al. Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation116(3), 329–343 (2007).
   PubMed Web of Science ®Google Scholar
• Tji-Joong Gan C, Lankhaar JW, Marcus JT et al. Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension. Am. J. Physiol. Heart Circ. Physiol.290(4), H1528–H1533 (2006).
   Google Scholar
• Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation104(4), 429–435 (2001).
   PubMed Web of Science ®Google Scholar
• Mainguy V, Maltais F, Saey D et al. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax65, 113–117 (2010).
   PubMed Web of Science ®Google Scholar
• Rich S. The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular? Circ. Heart Fail.2(2), 145–150 (2009).
   PubMed Web of Science ®Google Scholar
• Rich S. Executive Summary from the World Symposium on Primary Pulmonary Hypertension. World Health Organization, Evian, France (1998).
   Google Scholar
• Jing ZC, Xu XQ, Han ZY et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest132(2), 373–379 (2007).
   PubMed Web of Science ®Google Scholar
• Herrera EL, Zarate JS, Solano JF et al. Clinical–hemodynamic correlation of the NYHA/WHO system in idiopathic pulmonary artery hypertension. Clinical, therapeutic and long-term prognosis implications. Arch. Cardiol. Mex.78(2), 148–161 (2008).
   PubMedGoogle Scholar
• Taichman DB, McGoon MD, Harhay MO et al. Wide variation in clinicians’ assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension. Mayo Clin. Proc.84(7), 586–592 (2009).
   PubMed Web of Science ®Google Scholar
• Hansen JE, Sun XG, Yasunobu Y et al. Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension. Chest126(3), 816–824 (2004).
   PubMed Web of Science ®Google Scholar
• Arena R, Myers J, Guazzi M. The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review. Heart Fail. Rev.13(2), 245–269 (2008).
   PubMed Web of Science ®Google Scholar
• Hambrecht RP, Schuler GC, Muth T et al. Greater diagnostic sensitivity of treadmill versus cycle exercise testing of asymptomatic men with coronary artery disease. Am. J. Cardiol.70(2), 141–146 (1992).
   PubMed Web of Science ®Google Scholar
• Valli G, Vizza CD, Onorati P et al. Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension. Eur. J. Appl. Physiol.102(4), 417–424 (2008).
   PubMed Web of Science ®Google Scholar
• Myers J, Voodi L, Umann T, Froelicher VF. A survey of exercise testing: methods, utilization, interpretation, and safety in the VAHCS. J. Cardiopulm. Rehabil.20(4), 251–258 (2000).
   PubMedGoogle Scholar
• Balke B, Ware RW. An experimental study of physical fitness of Air Force personnel. US Armed Forces Med. J.10(6), 675–688 (1959).
   PubMedGoogle Scholar
• Naughton J, Balke B, Nagle F. Refinements in method of evaluation of physical conditioning before and after myocardial infarction. Am. J. Cardiol.14, 837–843 (1964).
   PubMed Web of Science ®Google Scholar
• Myers J, Bellin D. Ramp exercise protocols for clinical and cardiopulmonary exercise testing. Sports Med.30(1), 23–29 (2000).
   PubMed Web of Science ®Google Scholar
• Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur. Respir. Rev.19(115), 59–63 (2010).
   PubMedGoogle Scholar
• Janicki JS, Weber KT, Likoff MJ, Fishman AP. Exercise testing to evaluate patients with pulmonary vascular disease. Am. Rev. Respir. Dis.129(2 Pt 2), S93–S95 (1984).
   Google Scholar
• Wensel R, Opitz CF, Anker SD et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation106(3), 319–324 (2002).
   PubMed Web of Science ®Google Scholar
• Hansen JE, Ulubay G, Chow BF, Sun XG, Wasserman K. Mixed-expired and end-tidal CO2 distinguish between ventilation and perfusion defects during exercise testing in patients with lung and heart diseases. Chest132(3), 977–983 (2007).
   PubMed Web of Science ®Google Scholar
• Glaser S, Noga O, Koch B et al. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir. Med.103(2), 317–324 (2009).
   PubMed Web of Science ®Google Scholar
• Deboeck G, Niset G, Lamotte M, Vachiery JL, Naeije R. Exercise testing in pulmonary arterial hypertension and in chronic heart failure. Eur. Respir. J.23(5), 747–751 (2004).
   PubMed Web of Science ®Google Scholar
• Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP, Systrom DM. Exercise-induced pulmonary arterial hypertension. Circulation118(21), 2183–2189 (2008).
   PubMed Web of Science ®Google Scholar
• Ha JW, Choi D, Park S et al. Determinants of exercise-induced pulmonary hypertension in patients with normal left ventricular ejection fraction. Heart95(6), 490–494 (2009).
   PubMed Web of Science ®Google Scholar
• Reindl I, Wernecke KD, Opitz C et al. Impaired ventilatory efficiency in chronic heart failure: possible role of pulmonary vasoconstriction. Am. Heart J.136(5), 778–785 (1998).
   PubMed Web of Science ®Google Scholar
• Paciocco G, Martinez FJ, Bossone E et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur. Respir. J.17(4), 647–652 (2001).
   PubMed Web of Science ®Google Scholar
• Uren NG, Davies SW, Agnew JE et al. Reduction of mismatch of global ventilation and perfusion on exercise is related to exercise capacity in chronic heart failure. Br. Heart J.70(3), 241–246 (1993).
   PubMedGoogle Scholar
• Wada O, Asanoi H, Miyagi K et al. Importance of abnormal lung perfusion in excessive exercise ventilation in chronic heart failure. Am. Heart J.125(3), 790–798 (1993).
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Francis DP, Piepoli MF et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation103(7), 967–972 (2001).
   PubMed Web of Science ®Google Scholar
• Reybrouck T, Mertens L, Schulze-Neick I et al. Ventilatory inefficiency for carbon dioxide during exercise in patients with pulmonary hypertension. Clin. Physiol.18(4), 337–344 (1998).
   PubMedGoogle Scholar
• Jin X, Weil MH, Tang W et al. End-tidal carbon dioxide as a noninvasive indicator of cardiac index during circulatory shock. Crit. Care Med.28(7), 2415–2419 (2000).
   PubMed Web of Science ®Google Scholar
• Ornato JP, Garnett AR, Glauser FL. Relationship between cardiac output and the end-tidal carbon dioxide tension. Ann. Emerg. Med.19(10), 1104–1106 (1990).
   PubMed Web of Science ®Google Scholar
• Lewis GD, Shah RV, Pappagianopolas PP, Systrom DM, Semigran MJ. Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone. Circ. Heart Fail.1(4), 227–233 (2008).
   PubMed Web of Science ®Google Scholar
• American Thoracic Society and American College of Chest Physicians ATS/ACCP. statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med.167, 211–277 (2003).
   PubMed Web of Science ®Google Scholar
• Ridruejo R, Serrano P, Pascual I et al. Six-minute walk test in pulmonary hypertension of any etiology. Arch. Med.1(2), 1–7 (2009).
   Google Scholar
• James KB, Maurer J, Wolski K et al. Exercise hemodynamic findings in patients with exertional dyspnea. Tex. Heart Inst. J.27(2), 100–105 (2000).
   PubMed Web of Science ®Google Scholar
• Proudman SM, Stevens WM, Sahhar J, Celermajer D. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Intern. Med. J.37(7), 485–494 (2007).
   PubMed Web of Science ®Google Scholar
• Raeside DA, Chalmers G, Clelland J, Madhok R, Peacock AJ. Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring. Thorax53(10), 857–862 (1998).
   PubMed Web of Science ®Google Scholar
• Mereles D, Ehlken N, Kreuscher S et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation114(14), 1482–1489 (2006).
   PubMed Web of Science ®Google Scholar
• Capomolla S, Febo O, Caporotondi A et al. Non-invasive estimation of right atrial pressure by combined Doppler echocardiographic measurements of the inferior vena cava in patients with congestive heart failure. Ital. Heart J.1(10), 684–690 (2000).
   PubMedGoogle Scholar
• Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am. J. Cardiol.66(4), 493–496 (1990).
   PubMed Web of Science ®Google Scholar
• Bossone E, Bodini BD, Mazza A, Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest127(5), 1836–1843 (2005).
   PubMed Web of Science ®Google Scholar
• Tischler MD, Battle RW, Saha M, Niggel J, LeWinter MM. Observations suggesting a high incidence of exercise-induced severe mitral regurgitation in patients with mild rheumatic mitral valve disease at rest. J. Am. Coll. Cardiol.25(1), 128–133 (1995).
   PubMed Web of Science ®Google Scholar
• Tolle J, Waxman A, Systrom D. Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension. Med. Sci. Sports Exerc.40(1), 3–8 (2008).
   PubMed Web of Science ®Google Scholar
• Ferrazza AM, Martolini D, Valli G, Palange P. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration77(1), 3–17 (2009).
   PubMedGoogle Scholar
• Miyamoto S, Nagaya N, Satoh T et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med.161(2), 487–492 (2000).
   PubMed Web of Science ®Google Scholar
• Riley MS, Porszasz J, Engelen MP, Brundage BH, Wasserman K. Gas exchange responses to continuous incremental cycle ergometry exercise in primary pulmonary hypertension in humans. Eur. J. Appl. Physiol.83(1), 63–70 (2000).
   PubMed Web of Science ®Google Scholar
• Nagaya N, Shimizu Y, Satoh T et al. Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension. Heart87(4), 340–345 (2002).
   PubMed Web of Science ®Google Scholar
• Oudiz RJ, Roveran G, Hansen JE, Sun XG, Wasserman K. Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension. Eur. J. Heart Fail.9(9), 917–921 (2007).
   PubMed Web of Science ®Google Scholar
• Oudiz RJ, Midde R, Hovenesyan A et al. Usefulness of right-to-left shunting and poor exercise gas exchange for predicting prognosis in patients with pulmonary arterial hypertension. Am. J. Cardiol.105(8), 1186–1191 (2010).
   PubMed Web of Science ®Google Scholar
• Yetman AT, Taylor AL, Doran A, Ivy DD. Utility of cardiopulmonary stress testing in assessing disease severity in children with pulmonary arterial hypertension. Am. J. Cardiol.95(5), 697–699 (2005).
   PubMed Web of Science ®Google Scholar
• Raeside DA, Smith A, Brown A et al. Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension. Eur. Respir. J.16(2), 282–287 (2000).
   PubMed Web of Science ®Google Scholar
• Chenivesse C, Rachenne V, Fournier C et al. Cardiopulmonary exercise testing in exercise-induced pulmonary hypertension. Rev. Mal. Respir.23(2 Pt 1), 141–148 (2006).
   PubMed Web of Science ®Google Scholar
• Stone CD, Hennein HA, McIntosh CL et al. The results of operation in patients with hypertrophic cardiomyopathy and pulmonary hypertension. J. Thorac. Cardiovasc. Surg.100(3), 343–351 (1990).
   PubMed Web of Science ®Google Scholar
• Romeo F, Pelliccia F, Cristofani R, Martuscelli E, Reale A. Hypertrophic cardiomyopathy: is a left ventricular outflow tract gradient a major prognostic determinant? Eur. Heart J.11(3), 233–240 (1990).
   PubMed Web of Science ®Google Scholar
• Weitzenblum E, Chaouat A, Canuet M, Kessler R. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases. Semin. Respir. Crit. Care Med.30(04), 458–470 (2009).
   PubMed Web of Science ®Google Scholar
• Oudiz RJ. Pulmonary hypertension associated with left-sided heart disease. Clin. Chest Med.28(1), 233–241 (2007).
   PubMed Web of Science ®Google Scholar
• Ukkonen H, Burwash IG, Dafoe W et al. Is ventilatory efficiency (VE/VCO2 slope) associated with right ventricular oxidative metabolism in patients with congestive heart failure? Eur. J. Heart Fail.10(11), 1117–1122 (2008).
   PubMed Web of Science ®Google Scholar
• Ferreira AM, Tabet JY, Frankenstein L et al. Ventilatory efficiency and the selection of patients for heart transplantation. Circ. Heart Fail.3(3), 378–386 (2010).
   PubMed Web of Science ®Google Scholar
• Arena R, Myers J, Abella J et al. Development of a ventilatory classification system in patients with heart failure. Circulation115(18), 2410–2417 (2007).
   PubMed Web of Science ®Google Scholar
• Arena R, Owens DS, Arevalo J et al. Ventilatory efficiency and resting hemodynamics in hypertrophic cardiomyopathy. Med. Sci. Sports Exerc.40(5), 799–805 (2008).
   PubMed Web of Science ®Google Scholar
• Vonbank K, Funk GC, Marzluf B et al. Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD. Wien. Klin. Wochenschr.120(23–24), 749–755 (2008).
   PubMed Web of Science ®Google Scholar
• Holverda S, Bogaard HJ, Groepenhoff H et al. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respiration76(2), 160–167 (2008).
   PubMed Web of Science ®Google Scholar
• Callejas-Rubio JL, Moreno-Escobar UA, de la Fuente PM et al. Prevalence of exercise pulmonary arterial hypertension in scleroderma. J. Rheumatol.35(9), 1812–1816 (2008).
   PubMed Web of Science ®Google Scholar
• Barst RJ, Langleben D, Frost A et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J. Respir. Crit. Care Med.169(4), 441–447 (2004).
   PubMed Web of Science ®Google Scholar